Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gmo Product PlatformTSE:3695 -0.49%71 EBITDA Margin % is 15.00% as of Jun. 2026, which is 49% above its 10-year median of 10.07. GuruFocus rates TSE:3695 with a GF Score™ of 71/100 and a GF Value™ of 円1,590.34 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 2,826 Software companies, Gmo Product Platform ranks better than 61.85% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Gmo Product Platform EBITDA Margin % Related Terms
Gmo Product Platform EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Gmo Product Platform's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3695 vs MSFT, ORCL, PLTR: EBITDA Margin % Comparison
For the Software - Infrastructure subindustry, Gmo Product Platform's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gmo Product Platform EBITDA Margin % vs Software Industry
For the Software industry and Technology sector, Gmo Product Platform's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Gmo Product Platform's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gmo Product Platform (TSE:3695) has a EBITDA Margin % of 15.00% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gmo Product Platform and its competitors. This is 49% above median its historical median of 10.07. Over the past decade, Gmo Product Platform's EBITDA Margin % has ranged from 6.26 to 12.96. According to the industry distribution chart, Gmo Product Platform ranks #1078 out of 2826 companies in the Software industry, placing it in the top 38.1%.
Is Gmo Product Platform's EBITDA Margin % too high?
Gmo Product Platform's current EBITDA Margin % of 15.00% is 49% above median its 10-year median of 10.07. Over the past 10 years, this metric has ranged from a low of 6.26 to a high of 12.96. The Software industry median EBITDA Margin % is 8.26. Gmo Product Platform's value of 15.00% is 81.7% above this industry median. Based on the distribution chart, Gmo Product Platform ranks #1078 out of 2826 companies in the Software industry, which is above the industry midpoint. Overall, Gmo Product Platform has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Gmo Product Platform's EBITDA Margin % compare to MSFT and ORCL?
According to the Software industry distribution chart, Gmo Product Platform ranks #1078 out of 2826 companies for EBITDA Margin %. This puts Gmo Product Platform in the upper half of its industry. The industry median EBITDA Margin % is 8.26. Gmo Product Platform's value of 15.00% is 81.7% above this benchmark. Historically, Gmo Product Platform's own EBITDA Margin % has ranged from 6.26 to 12.96 over the past decade. While the company's 10-year median is 10.07 vs. the industry median of 8.26, Gmo Product Platform has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Software company?
The median EBITDA Margin % among Software companies is 8.26, based on 2,826 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gmo Product Platform's current EBITDA Margin % of 15.00% is 81.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gmo Product Platform and its competitors. For the Software industry, the median EBITDA Margin % is 8.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gmo Product Platform's current EBITDA Margin % is 15.00%, which is 49% above median its own 10-year median of 10.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gmo Product Platform stock overvalued right now?
Based on GuruFocus' analysis, Gmo Product Platform (TSE:3695) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,590.34, compared to a current price of 円1,431.00 — trading 10% below its estimated fair value. The current EBITDA Margin % is 15.00%, which is 49% above median its 10-year median of 10.07 and 81.7% above the Software industry median of 8.26. Gmo Product Platform's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Gmo Product Platform (TSE:3695), the current EBITDA Margin % is 15.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gmo Product Platform (TSE:3695) Overvalued in 2026?
Based on GuruFocus' analysis, Gmo Product Platform stock appears to be undervalued.
The current stock price of 円1,431.00 is trading 10% below its estimated GF Value™ of 円1,590.34.
GuruFocus considers Gmo Product Platform to be Modestly Undervalued.
Key valuation signals for TSE:3695:
EBITDA Margin %: 15.00% (49% above median its 10-year median of 10.07)
GF Value™: 円1,590.34 vs. price of 円1,431.00 (10% below fair value)
Industry Position: 81.7% above the Software median (#1078 of 2826)
No single metric tells the full story. See the TSE:3695 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gmo Product Platform Inc offers online payment and business-to-business payment platform services that help startups, tech companies, and SMEs improve payment processing and operational efficiency. The solutions of the company support various business models with digital payment infrastructure and finance-related services.
71GF Score
Get the complete analysis for TSE:3695
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3695 has been successfully added to your 
